cloperastine hydrochloride has been researched along with bufexamac in 1 studies
| Studies (cloperastine hydrochloride) | Trials (cloperastine hydrochloride) | Recent Studies (post-2010) (cloperastine hydrochloride) | Studies (bufexamac) | Trials (bufexamac) | Recent Studies (post-2010) (bufexamac) |
|---|---|---|---|---|---|
| 18 | 0 | 11 | 111 | 15 | 31 |
| Protein | Taxonomy | cloperastine hydrochloride (IC50) | bufexamac (IC50) |
|---|---|---|---|
| leucine aminopeptidase | Homo sapiens (human) | 0.31 | |
| M17 leucyl aminopeptidase | Plasmodium falciparum 3D7 | 0.41 | |
| M18 aspartyl aminopeptidase | Plasmodium falciparum 3D7 | 10.02 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 13.97 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.1288 | |
| M17 leucyl aminopeptidase | Plasmodium falciparum 3D7 | 1 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 81.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biagini, GA; Chandramohanadas, R; Darling, C; DeGrado, WF; Diamond, SL; Fisher, N; Greenbaum, DC; Jing, H; Jo, H; Lucumi, E; Napper, AD; Shone, AE; Ward, SA | 1 |
1 other study(ies) available for cloperastine hydrochloride and bufexamac
| Article | Year |
|---|---|
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
Topics: Animals; Antimalarials; Drug Resistance, Multiple; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum | 2010 |